First Hawaiian Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,924
| Closed | -$1.35M | – | 569 |
|
|
2024
Q4 | $1.35M | Sell |
50,924
-675
| -1% | -$18.3K | 0.04% | 335 |
|
|
2024
Q3 | $1.49M | Buy |
51,599
+14,872
| +40% | +$434K | 0.05% | 311 |
|
|
2024
Q2 | $1.03M | Sell |
36,727
-144
| -0.4% | -$3.96K | 0.03% | 363 |
|
|
2024
Q1 | $1.02M | Sell |
36,871
-9,195
| -20% | -$255K | 0.03% | 397 |
|
|
2023
Q4 | $1.33M | Sell |
46,066
-1,191
| -3% | -$36K | 0.04% | 321 |
|
|
2023
Q3 | $1.57M | Sell |
47,257
-609
| -1% | -$21.5K | 0.05% | 271 |
|
|
2023
Q2 | $1.76M | Sell |
47,866
-2,201
| -4% | -$85.7K | 0.06% | 246 |
|
|
2023
Q1 | $2.04M | Sell |
50,067
-13,443
| -21% | -$581K | 0.07% | 216 |
|
|
2022
Q4 | $3.25M | Buy |
63,510
+5,885
| +10% | +$282K | 0.12% | 116 |
|
|
2022
Q3 | $2.52M | Sell |
57,625
-1,024
| -2% | -$49.8K | 0.1% | 154 |
|
|
2022
Q2 | $3.08M | Buy |
58,649
+3,595
| +7% | +$183K | 0.11% | 129 |
|
|
2022
Q1 | $2.85M | Sell |
55,054
-266
| -0.5% | -$13.8K | 0.09% | 162 |
|
|
2021
Q4 | $3.27M | Buy |
55,320
+6,729
| +14% | +$333K | 0.1% | 149 |
|
|
2021
Q3 | $2.09M | Sell |
48,591
-217
| -0.4% | -$9.61K | 0.09% | 153 |
|
|
2021
Q2 | $1.91M | Sell |
48,808
-14,126
| -22% | -$549K | 0.08% | 160 |
|
|
2021
Q1 | $2.28M | Sell |
62,934
-625
| -1% | -$22.2K | 0.1% | 145 |
|
|
2020
Q4 | $2.34M | Sell |
63,559
-9,655
| -13% | -$354K | 0.11% | 128 |
|
|
2020
Q3 | $2.55M | Sell |
73,214
-22,663
| -24% | -$795K | 0.13% | 106 |
|
|
2020
Q2 | $2.98M | Sell |
95,877
-3,246
| -3% | -$110K | 0.16% | 91 |
|
|
2020
Q1 | $3.07M | Buy |
99,123
+25,302
| +34% | +$862K | 0.19% | 74 |
|
|
2019
Q4 | $2.74M | Buy |
73,821
+13,410
| +22% | +$478K | 0.13% | 112 |
|
|
2019
Q3 | $2.06M | Sell |
60,411
-22,818
| -27% | -$830K | 0.11% | 143 |
|
|
2019
Q2 | $3.42M | Sell |
83,229
-1,132
| -1% | -$45K | 0.18% | 72 |
|
|
2019
Q1 | $3.4M | Sell |
84,361
-1,997
| -2% | -$80K | 0.18% | 75 |
|
|
2018
Q4 | $3.58M | Sell |
86,358
-25,312
| -23% | -$1.05M | 0.21% | 65 |
|
|
2018
Q3 | $4.67M | Buy |
111,670
+85,134
| +321% | +$3.28M | 0.24% | 57 |
|
|
2018
Q2 | $914K | Buy |
26,536
+20,109
| +313% | +$687K | 0.12% | 54 |
|
|
2018
Q1 | $217K | Sell |
6,427
-143
| -2% | -$4.92K | 0.03% | 102 |
|
|
2017
Q4 | $226K | Buy |
6,570
+88
| +1% | +$3K | 0.03% | 100 |
|
|
2017
Q3 | $220K | Buy |
6,482
+102
| +2% | +$3.28K | 0.03% | 96 |
|
|
2017
Q2 | $203K | Sell |
6,380
-1,787
| -22% | -$56.4K | 0.03% | 95 |
|
|
2017
Q1 | $265K | Sell |
8,167
-494
| -6% | -$15.6K | 0.04% | 80 |
|
|
2016
Q4 | $266K | Sell |
8,661
-388
| -4% | -$11.8K | 0.04% | 73 |
|
|
2016
Q3 | $291K | Buy |
9,049
+26
| +0.3% | +$869 | 0.05% | 63 |
|
|
2016
Q2 | $302K | Sell |
9,023
-31
| -0.3% | -$989 | 0.05% | 66 |
|
|
2016
Q1 | $254K | Sell |
9,054
-580
| -6% | -$16.6K | 0.04% | 77 |
|
|
2015
Q4 | $296K | Buy |
9,634
+453
| +5% | +$14.3K | 0.05% | 73 |
|
|
2015
Q3 | $274K | Buy |
9,181
+1,048
| +13% | +$33.6K | 0.05% | 73 |
|
|
2015
Q2 | $259K | Buy |
8,133
+8
| +0.1% | +$261 | 0.04% | 74 |
|
|
2015
Q1 | $268K | Buy |
+8,125
| New | +$258K | 0.04% | 71 |
|
|
2014
Q2 | – | Sell |
-8,843
| Closed | -$269K | – | 127 |
|
|
2014
Q1 | $269K | Sell |
8,843
-2,366
| -21% | -$70.5K | 0.05% | 119 |
|
|
2013
Q4 | $326K | Sell |
11,209
-1,643
| -13% | -$47.8K | 0.06% | 118 |
|
|
2013
Q3 | $351K | Sell |
12,852
-13,927
| -52% | -$379K | 0.07% | 112 |
|
|
2013
Q2 | $712K | Buy |
+26,779
| New | +$740K | 0.15% | 42 |
|
Other funds holding PFE
TIM
First Hawaiian Bank's PFE Position: Q1 2025 in Review
First Hawaiian Bank sold out of Pfizer (PFE) in Q1 2025, closing a stake of 50,924 shares — an estimated $1.35M sold.
First Hawaiian Bank first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $4.67M in Q3 2018. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- First Hawaiian Bank reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- First Hawaiian Bank sold 50,924 Pfizer shares in Q1 2025, an estimated $1.35M.
- First Hawaiian Bank first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
- First Hawaiian Bank's Pfizer position peaked at $4.67M in Q3 2018.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.